These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24700157)

  • 1. The kidney and lipids: preface.
    Kasiske B; Saito T
    Clin Exp Nephrol; 2014 Apr; 18(2):180-4. PubMed ID: 24700157
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.
    Opazo-Ríos L; Mas S; Marín-Royo G; Mezzano S; Gómez-Guerrero C; Moreno JA; Egido J
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGC1α in the kidney.
    Lynch MR; Tran MT; Parikh SM
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F1-F8. PubMed ID: 28931521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in diabetic kidney disease: good use and pitfalls.
    Titan S
    Arch Endocrinol Metab; 2016 Apr; 60(2):92-4. PubMed ID: 27191045
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammatory cytokines in diabetic nephropathy.
    Donate-Correa J; Martín-Núñez E; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
    J Diabetes Res; 2015; 2015():948417. PubMed ID: 25785280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [WCN2013 satellite symposium "kidney and lipids" Report of the WCN2013 satellite symposium"kidney and lipids"].
    Saito T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1257-62. PubMed ID: 24288960
    [No Abstract]   [Full Text] [Related]  

  • 7. The landscape of diabetic kidney disease transformed.
    Tuttle KR
    Nat Rev Nephrol; 2020 Feb; 16(2):67-68. PubMed ID: 31831876
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer.
    Darshi M; Van Espen B; Sharma K
    Am J Nephrol; 2016; 44(2):92-103. PubMed ID: 27410520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney disease and cardiovascular disease: implications of dyslipidemia.
    Keane WF; Lyle PA
    Cardiol Clin; 2005 Aug; 23(3):363-72. PubMed ID: 16084284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
    Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA
    Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174
    [No Abstract]   [Full Text] [Related]  

  • 11. Slowing the progression of chronic kidney disease.
    Herrington WG; Mason PD
    Br J Hosp Med (Lond); 2009 Nov; 70(11):634-8. PubMed ID: 20081590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are SGLT2 Inhibitors Ready for Prime Time for CKD?
    Pecoits-Filho R; Perkovic V
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):318-320. PubMed ID: 28893920
    [No Abstract]   [Full Text] [Related]  

  • 13. [Abnormal lipoprotein metabolism in CKD].
    Hirano T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1276-9. PubMed ID: 24288963
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of IL-20 in chronic kidney disease and diabetic nephropathy: Pathogenic and therapeutic implications.
    Chang MS; Hsu YH
    J Leukoc Biol; 2018 Nov; 104(5):919-923. PubMed ID: 29999545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids and diabetic renal disease.
    Cooper ME; Jandeleit-Dahm KA
    Curr Diab Rep; 2005 Dec; 5(6):445-8. PubMed ID: 16316596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Diabetes Medications Targeting the Incretin System on the Kidney.
    MacIsaac RJ; Thomas MC
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):321-323. PubMed ID: 29321176
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of Nephrin Phosphorylation in Diabetes and Chronic Kidney Injury.
    Denhez B; Geraldes P
    Adv Exp Med Biol; 2017; 966():149-161. PubMed ID: 28639250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease.
    Gilbert RE
    Diabetes; 2017 Apr; 66(4):791-800. PubMed ID: 28325740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of glutathione-S-transferase activity in diabetic nephropathy.
    Tesauro M; Nisticò S; Noce A; Tarantino A; Marrone G; Costa A; Rovella V; Di Cola G; Campia U; Lauro D; Cardillo C; Di Daniele N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):129-33. PubMed ID: 25816416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function deterioration in adult patients with type-2 diabetes.
    Bramlage P; Lanzinger S; Hess E; Fahrner S; Heyer CHJ; Friebe M; Buschmann I; Danne T; Holl RW; Seufert J
    BMC Nephrol; 2020 Jul; 21(1):312. PubMed ID: 32727401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.